Polaris Partners

All recorded activity

By stage

Series B2

Series A1

Undisclosed1

Biotech4

United States4

4 in all activity

Jun 2

Develops novel therapeutics for glaucoma and retinal diseases

$17MSeries A

Role not disclosed

Mar 18

Develops a novel class of potent and precise antibody therapies to treat a broad range of cancers

$77MSeries B

Role not disclosed

Jan 27

Develops precision immunoregulatory medicines based on tissue Treg biology

$50MUndisclosed

Role not disclosed

Jan 8

Develops novel bispecific antibodies for targeted degradation of extracellular proteins in oncolo...

$107MSeries B

Role not disclosed